No significant strengths identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| AGOAssured Guaranty Ltd. | 3.95B | 85.56 | 12.45 | -19.8% | 42.14% | 7.01% | 1.19% | 0.31 |
| AMBCAmbac Financial Group, Inc. | 276.45M | 6.31 | 4.44 | 89.06% | -7.87% | -67.99% | 0.28% | 0.13 |
| MBIMBIA Inc. | 354.47M | 7.02 | -0.75 | 5% | -195.51% |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 854M | 289M | 405M | 159M | 281M | 282M | 159M | 154M | 7M | 42M |
| Revenue Growth % | -0.32% | -0.66% | 0.4% | -0.61% | 0.77% | 0% | -0.44% | -0.03% | -0.95% | 5% |
| Medical Costs & Claims | 173M | 260M | 706M | 83M | 253M | 540M | 356M | 46M | 182M | 188M |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 681M | 29M | -301M | 76M | 28M | -258M | -197M | 108M | -175M | -146M |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | -0.37% | -0.96% | -11.38% | 1.25% | -0.63% | -10.21% | 0.24% | 1.55% | -2.62% | 0.17% |
| Operating Expenses | 392M | 368M | 360M | 372M | 385M | 320M | 248M | 256M | 309M | 295M |
| OpEx / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Combined Ratio % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 289M | -339M | -661M | -296M | -357M | -578M | -445M | -148M | -484M | -441M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -0.55% | -2.17% | -0.95% | 0.55% | -0.21% | -0.62% | 0.23% | 0.67% | -2.27% | 0.09% |
| EBITDA | 527M | -117M | -389M | -3M | -74M | -350M | -264M | 32M | -273M | -232M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 238M | 222M | 272M | 293M | 283M | 228M | 181M | 180M | 211M | 209M |
| Non-Operating Income | -238M | -222M | -272M | -293M | -283M | -228M | -181M | -180M | -211M | -209M |
| Pretax Income | 289M | -339M | -661M | -296M | -357M | -578M | -445M | -148M | -484M | -441M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 109M | -1M | 944M | 0 | 2M | 0 | 0 | 1M | 0 | 0 |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 180M | -338M | -1.6B | -296M | -359M | -578M | -445M | -203M | -487M | -444M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -0.68% | -2.88% | -3.75% | 0.82% | -0.21% | -0.61% | 0.23% | 0.54% | -1.4% | 0.09% |
| EPS (Diluted) | 1.06 | -2.54 | -13.50 | -3.33 | -4.43 | -9.78 | -8.99 | -3.92 | -10.19 | -9.42 |
| EPS Growth % | -0.62% | -3.4% | -4.31% | 0.75% | -0.33% | -1.21% | 0.08% | 0.56% | -1.6% | 0.08% |
| EPS (Basic) | 1.06 | -2.54 | -13.50 | -3.33 | -4.43 | -9.78 | -8.99 | -3.92 | -10.19 | -9.42 |
| Diluted Shares Outstanding | 164.87M | 133M | 118.93M | 89.01M | 81.01M | 59.07M | 49.47M | 49.8M | 48.21M | 47.44M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 14.86B | 11.14B | 9.1B | 8.08B | 7.28B | 5.75B | 4.7B | 3.38B | 2.61B | 2.17B |
| Asset Growth % | -0.09% | -0.25% | -0.18% | -0.11% | -0.1% | -0.21% | -0.18% | -0.28% | -0.23% | -0.17% |
| Total Investment Assets | 11.38B | 8.02B | 7.67B | 5.67B | 7.67B | 5.35B | 5.38B | 4.89B | 362M | 1.68B |
| Long-Term Investments | 9.66B | 6.54B | 5.57B | 5.08B | 4.42B | 2.81B | 2.85B | 2.72B | 362M | 1.65B |
| Short-Term Investments | 5.87B | 5.25B | 4.3B | 3.81B | 3.24B | 2.54B | 2.53B | 2.17B | 0 | 1.42B |
| Total Current Assets | 827M | 738M | 649M | 5.95B | 5.27B | 4.6B | 4.17B | 2.53B | 436M | 0 |
| Cash & Equivalents | 522M | 187M | 146M | 280M | 83M | 167M | 160M | 66M | 107M | 87M |
| Receivables | 0 | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | 0 | 0 | 2.45B | 0 | 2.01B | 716M | 2.03B | -1.82B |
| Goodwill & Intangibles | 168M | 118M | 95M | 74M | 60M | 50M | 42M | 35M | 31M | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 168M | 118M | 95M | 74M | 60M | 50M | 42M | 35M | 31M | 0 |
| PP&E (Net) | -168M | -118M | 5.32B | 4.87B | 21M | 20M | 18M | 17M | 15M | 0 |
| Other Assets | -9.66B | -6.54B | -5.57B | -5.08B | -203M | -212M | -160M | -240M | 1.23B | -1.65B |
| Total Liabilities | 11.11B | 7.9B | 7.67B | 6.94B | 6.45B | 5.6B | 5B | 4.25B | 4.25B | 4.24B |
| Total Debt | 7.97B | 5.12B | 4.55B | 4.71B | 4.45B | 3.56B | 3.21B | 3.1B | 3.16B | 3.22B |
| Net Debt | 7.45B | 4.93B | 4.41B | 4.43B | 4.36B | 3.4B | 3.05B | 3.04B | 3.06B | 3.14B |
| Long-Term Debt | 7.97B | 576M | 5.17B | 4.71B | 427M | 312M | 3.21B | 3.1B | 3.16B | 3.22B |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100M | 0 |
| Total Current Liabilities | 548M | 696M | 237M | 138M | 60M | 12M | 3M | 434M | 465M | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 1.89B | 1.47B | 297M | 5M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -38M | -544M | -37M | -35M | 24M | -1.04B | -57M | 429M | 360M | 0 |
| Deferred Taxes | 0 | 1000K | 1000K | 1000K | 1000K | 0 | 1000K | 1000K | 1000K | 0 |
| Other Liabilities | 3.14B | 1.54B | -3.3B | 2.26B | 0 | 1.19B | -3.21B | 1.15B | 457M | -3.22B |
| Total Equity | 3.74B | 3.24B | 1.43B | 1.13B | 839M | 149M | -300M | -876M | -1.65B | -2.08B |
| Equity Growth % | -0.05% | -0.13% | -0.56% | -0.21% | -0.26% | -0.82% | -3.01% | -1.92% | -0.88% | -0.26% |
| Shareholders Equity | 3.73B | 3.23B | 1.41B | 1.12B | 826M | 136M | -313M | -882M | -1.66B | -2.09B |
| Minority Interest | 12M | 12M | 12M | 13M | 13M | 13M | 13M | 6M | 10M | 13M |
| Retained Earnings | 3.04B | 2.7B | 1.09B | 966M | 607M | -13M | -458M | -653M | -1.14B | -1.59B |
| Common Stock | 282M | 284M | 284M | 284M | 283M | 283M | 283M | 283M | 283M | 283M |
| Accumulated OCI | -61M | -128M | -19M | -156M | -2M | 115M | 100M | -283M | -139M | -128M |
| Return on Equity (ROE) | 0.05% | -0.1% | -0.69% | -0.23% | -0.36% | -1.17% | - | - | - | - |
| Return on Assets (ROA) | 0.01% | -0.03% | -0.16% | -0.03% | -0.05% | -0.09% | -0.09% | -0.05% | -0.16% | -0.19% |
| Equity / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / Equity | 2.13x | 1.58x | 3.19x | 4.17x | 5.30x | 23.91x | - | - | - | - |
| Book Value per Share | 22.69 | 24.35 | 11.98 | 12.72 | 10.36 | 2.52 | -6.06 | -17.59 | -34.16 | -43.76 |
| Tangible BV per Share | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -55M | -142M | -630M | -319M | -368M | -390M | 511M | -418M | -195M | -176M |
| Operating CF Growth % | 0.83% | -1.58% | -3.44% | 0.49% | -0.15% | -0.06% | 2.31% | -1.82% | 0.53% | 0.1% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 180M | -338M | -1.6B | -296M | -359M | -578M | -445M | -149M | -484M | -441M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | -12M | 0 | -12M | 0 | 0 | 0 |
| Stock-Based Compensation | 20M | 16M | 10M | 6M | 12M | 0 | 12M | 0 | 0 | 0 |
| Deferred Taxes | 107M | -5M | 940M | -35M | 13M | 12M | -3M | 0 | 0 | 0 |
| Other Non-Cash Items | -157M | 275M | -36M | 207M | -30M | -61M | 9M | 25M | 173M | 64M |
| Working Capital Changes | -185M | -74M | 71M | -195M | 8M | 237M | 950M | -294M | 116M | 201M |
| Cash from Investing | 817M | 2.42B | 1.2B | 1.21B | 1.27B | 1.74B | -61M | 623M | 767M | 287M |
| Capital Expenditures | -3M | -1M | -1M | -1M | 74M | 0 | -1M | 0 | 2M | 0 |
| Acquisitions | 7M | 1M | 18M | -7M | 70M | 0 | 1M | 2M | 0 | 0 |
| Purchase of Investments | -2.54B | -2.86B | -2.07B | -2.45B | -2.29B | -1.33B | -1.53B | -1.17B | -667M | -325M |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Investing | 786M | 133M | 109M | 1.01B | -255M | 16M | 76M | 18M | -4M | 19M |
| Cash from Financing | -1.01B | -2.54B | -611M | -752M | -1.1B | -1.26B | -457M | -285M | -542M | -132M |
| Dividends Paid | 0 | 0 | 0 | -112M | 0 | 0 | -60M | 0 | -409M | 0 |
| Share Repurchases | -303M | -108M | -330M | -44M | -106M | -200M | -1M | -3M | -38M | -4M |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Other Financing | -91M | -78M | -26M | -25M | -18M | -36M | 60M | -46M | 0 | -9M |
| Net Change in Cash | -260M | -335M | -41M | 134M | -197M | 84M | -7M | -82M | 30M | -21M |
| Exchange Rate Effect | -1000K | -1000K | -1000K | -1000K | 0 | 1000K | 0 | -1000K | 0 | 0 |
| Cash at Beginning | 782M | 522M | 187M | 146M | 280M | 83M | 167M | 160M | 78M | 108M |
| Cash at End | 522M | 187M | 146M | 280M | 83M | 167M | 160M | 78M | 108M | 87M |
| Free Cash Flow | -58M | -143M | -631M | -320M | -294M | -390M | 510M | -418M | -195M | -176M |
| FCF Growth % | 0.83% | -1.47% | -3.41% | 0.49% | 0.08% | -0.33% | 2.31% | -1.82% | 0.53% | 0.1% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF per Share | -0.35 | -1.08 | -5.31 | -3.59 | -3.63 | -6.6 | 10.31 | -8.39 | -4.05 | -3.71 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 66.16% | 217.3% | 263.21% | 286.16% | 227.05% | 304.96% | 379.87% | 196.1% | 7014.29% | 1150% |
| Medical Cost Ratio | 20.26% | 89.97% | 174.32% | 52.2% | 90.04% | 191.49% | 223.9% | 29.87% | 2600% | 447.62% |
| Return on Equity (ROE) | 4.68% | -9.68% | -68.83% | -23.15% | -36.43% | -117% | - | - | - | - |
| Return on Assets (ROA) | 1.16% | -2.6% | -15.87% | -3.45% | -4.67% | -8.87% | -8.52% | -5.03% | -16.28% | -18.6% |
| Equity / Assets | 25.18% | 29.08% | 15.67% | 14.02% | 11.52% | 2.59% | -6.39% | -25.96% | -63.2% | -95.76% |
| Book Value / Share | 22.69 | 24.35 | 11.98 | 12.72 | 10.36 | 2.52 | -6.06 | -17.59 | -34.16 | -43.76 |
| Debt / Equity | 2.13x | 1.58x | 3.19x | 4.17x | 5.30x | 23.91x | - | - | - | - |
| Revenue Growth | -32.38% | -66.16% | 40.14% | -60.74% | 76.73% | 0.36% | -43.62% | -3.14% | -95.45% | 500% |
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| U S Public Finance Insurance | 443M | 423M | 427M | 200M | 182M | 21M | - | 110M | - | 99M |
| U S Public Finance Insurance Growth | - | -4.51% | 0.95% | -53.16% | -9.00% | -88.46% | - | - | - | - |
| Corporate Operations | 148M | 169M | 67M | 82M | 99M | 1M | - | 166M | - | 96M |
| Corporate Operations Growth | - | 14.19% | -60.36% | 22.39% | 20.73% | -98.99% | - | - | - | - |
| International And Structured Finance Insurance | - | - | - | - | - | 55M | 163M | 19M | 5M | 21M |
| International And Structured Finance Insurance Growth | - | - | - | - | - | - | 196.36% | -88.34% | -73.68% | 320.00% |
| Structured Finance And International Insurance | 819M | 425M | 31M | 185M | -21M | - | - | - | - | - |
| Structured Finance And International Insurance Growth | - | -48.11% | -92.71% | 496.77% | -111.35% | - | - | - | - | - |
| Advisory Services | 23M | - | - | - | - | - | - | - | - | - |
| Advisory Services Growth | - | - | - | - | - | - | - | - | - | - |
| Conduits | 3M | - | - | - | - | - | - | - | - | - |
| Conduits Growth | - | - | - | - | - | - | - | - | - | - |
MBIA Inc. (MBI) grew revenue by 500.0% over the past year. This is strong growth.
MBIA Inc. (MBI) reported a net loss of $174.0M for fiscal year 2024.
MBIA Inc. (MBI) has a combined ratio of 1150.0%. A ratio above 100% means claims and expenses exceed premiums.